Loading...
Integra LifeSciences Holdings Corporation
IART•NASDAQ
Healthcare
Medical - Devices
$13.11
$0.40(3.15%)
Integra LifeSciences Holdings Corporation (IART) Financial Performance & Income Statement Overview
Review Integra LifeSciences Holdings Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.47%
↑ 4.47%
Operating Income Growth
-74.53%
↓ 74.53%
Net Income Growth
-110.25%
↓ 110.25%
Operating Cash Flow Growth
-7.55%
↓ 7.55%
Operating Margin
2.91%
↑ 2.91%
Gross Margin
65.53%
↑ 65.53%
Net Profit Margin
-1.78%
↓ 1.78%
ROE
-2.52%
↓ 2.52%
ROIC
4.86%
↑ 4.86%
Integra LifeSciences Holdings Corporation (IART) Income Statement & Financial Overview
Review Integra LifeSciences Holdings Corporation's (IART) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $442.65M | $380.83M | $418.18M | $368.87M |
| Cost of Revenue | $193.57M | $180.60M | $185.71M | $162.04M |
| Gross Profit | $249.07M | $200.24M | $232.47M | $206.83M |
| Gross Profit Ratio | $0.56 | $0.53 | $0.56 | $0.56 |
| R&D Expenses | $31.21M | $27.43M | $25.03M | $26.96M |
| SG&A Expenses | $178.52M | $177.19M | $172.18M | $165.80M |
| Operating Expenses | $213.44M | $208.39M | $197.22M | $202.87M |
| Total Costs & Expenses | $407.02M | $388.98M | $382.92M | $364.91M |
| Interest Income | $4.89M | $5.05M | $5.06M | $5.04M |
| Interest Expense | $18.98M | $19.37M | $18.65M | $13.62M |
| Depreciation & Amortization | $37.59M | $35.96M | $36.78M | $30.57M |
| EBITDA | $79.11M | $39.11M | $45.27M | $71.07M |
| EBITDA Ratio | $0.18 | $0.10 | $0.17 | $0.11 |
| Operating Income | $35.63M | -$8.15M | $35.25M | $3.96M |
| Operating Income Ratio | $0.08 | -$0.02 | $0.08 | $0.01 |
| Other Income/Expenses (Net) | -$13.09M | -$12.21M | -$12.16M | -$9.19M |
| Income Before Tax | $22.54M | -$20.36M | -$15.19M | -$5.23M |
| Income Before Tax Ratio | $0.05 | -$0.05 | -$0.04 | -$0.01 |
| Income Tax Expense | $3.11M | -$9.67M | -$2.78M | -$1.95M |
| Net Income | $19.43M | -$10.70M | -$12.40M | -$3.28M |
| Net Income Ratio | $0.04 | -$0.03 | -$0.03 | -$0.009 |
| EPS | $0.25 | -$0.14 | -$0.16 | -$0.04 |
| Diluted EPS | $0.25 | -$0.14 | -$0.16 | -$0.04 |
| Weighted Avg Shares Outstanding | $77.01M | $76.45M | $77.41M | $77.73M |
| Weighted Avg Shares Outstanding (Diluted) | $77.01M | $76.45M | $77.41M | $77.73M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan